(TGTX) TG Therapeutics - Performance 78.5% in 12m
TGTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
30.69%
#14 in Peer-Group
Rel. Strength
92.19%
#601 in Stock-Universe
Total Return 12m
78.47%
#15 in Peer-Group
Total Return 5y
65.04%
#19 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 142 |
| P/E Forward | 42.9 |
| High / Low | USD |
|---|---|
| 52 Week High | 45.51 USD |
| 52 Week Low | 17.21 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 61.86 |
| Buy/Sell Signal +-5 | -1.16 |
| Support / Resistance | Levels |
|---|---|
| Support | 37.3, 34.7, 33.6, 30.6, 24.8, 23.4 |
| Resistance | 39.2 |
12m Total Return: TGTX (78.5%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
1.62% | -10.4% | 150% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-2.07% | 25.1% | -6.95% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.57% | 27.9% | 14.5% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: TGTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TGTX
| Total Return (including Dividends) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.54% | 3.06% | 3.54% |
| 3 Months | -2.74% | 12.25% | 16.07% |
| 12 Months | 78.47% | -13.98% | 12.18% |
| 5 Years | 65.04% | -27.36% | 107.69% |
| Trend Score (consistency of price movement) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 54.2% | 76.5% | 91.9% |
| 3 Months | -13.3% | 79.3% | 97.5% |
| 12 Months | 87.7% | -87.3% | 47% |
| 5 Years | -7.5% | -51.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th66.00 | 3.38% | 2.90% |
| 3 Month | %th27.50 | -13.36% | -16.21% |
| 12 Month | %th93.00 | 107.46% | 59.10% |
| 5 Years | %th92.50 | 127.20% | -20.53% |
FAQs
Does TG Therapeutics (TGTX) outperform the market?
Yes,
over the last 12 months TGTX made 78.47%, while its related Sector, the SPDR S&P Biotech (XBI) made -13.98%.
Over the last 3 months TGTX made -2.74%, while XBI made 12.25%.
Performance Comparison TGTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TGTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6.3% | 3% | 20.2% | 66% |
| US NASDAQ 100 | QQQ | 5.8% | 2.2% | 17.8% | 66% |
| German DAX 40 | DAX | 7.3% | 5% | 9.4% | 50% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.7% | 1.6% | 16.2% | 59% |
| Hongkong Hang Seng | HSI | 5.7% | 4.1% | -1.8% | 44% |
| India NIFTY 50 | INDA | 8.1% | 6% | 18.8% | 82% |
| Brasil Bovespa | EWZ | 10.9% | 9.5% | 8.1% | 78% |
TGTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 7.3% | 4.7% | 16% | 55% |
| Consumer Discretionary | XLY | 6% | 4% | 28.9% | 63% |
| Consumer Staples | XLP | 8.2% | 7.3% | 19.5% | 72% |
| Energy | XLE | 8.4% | 6.8% | 30.4% | 81% |
| Financial | XLF | 7.7% | 4% | 20.7% | 57% |
| Health Care | XLV | 8.4% | 8.4% | 30.6% | 87% |
| Industrial | XLI | 5.9% | 1.9% | 14.3% | 57% |
| Materials | XLB | 8.9% | 4.9% | 22.4% | 78% |
| Real Estate | XLRE | 6.9% | 7.1% | 21.4% | 72% |
| Technology | XLK | 6% | 0.3% | 14.4% | 68% |
| Utilities | XLU | 5.6% | 4.6% | 17.5% | 57% |
| Aerospace & Defense | XAR | 3.5% | -2.7% | -0.4% | 30% |
| Biotech | XBI | 5.2% | 3.5% | 28.8% | 92% |
| Homebuilder | XHB | 8% | 1% | 33.6% | 85% |
| Retail | XRT | 7.5% | 3.7% | 24.4% | 74% |
TGTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8.8% | 10.8% | 36.6% | 85% |
| Natural Gas | UNG | 1.8% | 15% | 44.5% | 71% |
| Gold | GLD | 5.8% | 8.2% | 2.5% | 41% |
| Silver | SLV | 3.7% | 2.8% | 3.3% | 56% |
| Copper | CPER | 5% | -7.1% | 1.5% | 56% |
TGTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 7.8% | 6.7% | 25.7% | 83% |
| iShares High Yield Corp. Bond | HYG | 6.8% | 5.7% | 22.2% | 70% |